Deal snapshot: InvoX Pharma to Extends Offer to Acquire F-star Therapeutics for USD 7.12/Share.

MANews-(C)2009-2022

UK-based pharmaceutical company invoX Pharma Ltd -star Therapeutics, Inc. has extended the expiration of its previously announced tender offer for all of the issued and outstanding common shares of UK-based clinical-stage biopharmaceutical company F-star (NASDAQ: FSTX) for USD 7.12 per share, the...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT